ZA915593B - Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same - Google Patents
Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the sameInfo
- Publication number
- ZA915593B ZA915593B ZA915593A ZA915593A ZA915593B ZA 915593 B ZA915593 B ZA 915593B ZA 915593 A ZA915593 A ZA 915593A ZA 915593 A ZA915593 A ZA 915593A ZA 915593 B ZA915593 B ZA 915593B
- Authority
- ZA
- South Africa
- Prior art keywords
- virus
- mounth
- foot
- disease
- herpesvirus
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 2
- 201000010099 disease Diseases 0.000 title 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 2
- 239000002245 particle Substances 0.000 title 1
- 241001529453 unidentified herpesvirus Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 239000013603 viral vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55659390A | 1990-07-24 | 1990-07-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA915593B true ZA915593B (en) | 1993-03-31 |
Family
ID=24221994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA915593A ZA915593B (en) | 1990-07-24 | 1991-07-17 | Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0471457A3 (xx) |
| AU (1) | AU8126391A (xx) |
| CA (1) | CA2047585A1 (xx) |
| IE (1) | IE912591A1 (xx) |
| ZA (1) | ZA915593B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0598759A4 (en) * | 1991-07-18 | 1998-06-03 | Syntro Corp | RECOMBINANT VIRUS OF INFECTIOUS RHINE TRACHEITIS OF CATTLE. |
| WO1994024296A2 (en) * | 1993-04-19 | 1994-10-27 | University Of Saskatchewan | Recombinant bovine herpesvirus type 1 vaccines |
| GB9720633D0 (en) * | 1997-09-29 | 1997-11-26 | Univ Bristol | BHV-2 vector |
| GB9816775D0 (en) * | 1998-07-31 | 1998-09-30 | Efstathiou Stacey | Herpesviral vectors for gene delivery |
| FR2810888B1 (fr) | 2000-06-29 | 2004-07-30 | Merial Sas | Vaccin contre la fievre aphteuse |
| MX388708B (es) | 2014-09-23 | 2025-03-20 | Boehringer Ingelheim Animal Health Usa Inc | Vacunas recombinantes contra fmdv y sus usos. |
| TWI760322B (zh) | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0256092B1 (en) * | 1986-01-27 | 1998-04-08 | Syntro Corporation | Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same |
| JPH02501186A (ja) * | 1987-06-22 | 1990-04-26 | メディコ ラブス アクチェンゲゼルシャフト | 異種ウイルス性ペプチド粒子の免疫原 |
| AU2888089A (en) * | 1988-01-26 | 1989-07-27 | Baylor College Of Medicine | Infectious bovine rhinotracheitis virus insertion mutants, vaccines containing same, and methods for the production and use of same |
| GB8920357D0 (en) * | 1989-09-08 | 1989-10-25 | Wellcome Found | Peptides |
-
1991
- 1991-07-17 ZA ZA915593A patent/ZA915593B/xx unknown
- 1991-07-22 EP EP19910306646 patent/EP0471457A3/en not_active Withdrawn
- 1991-07-22 AU AU81263/91A patent/AU8126391A/en not_active Abandoned
- 1991-07-23 CA CA002047585A patent/CA2047585A1/en not_active Abandoned
- 1991-07-23 IE IE259191A patent/IE912591A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE912591A1 (en) | 1992-01-29 |
| CA2047585A1 (en) | 1992-01-25 |
| EP0471457A3 (en) | 1992-03-04 |
| EP0471457A2 (en) | 1992-02-19 |
| AU8126391A (en) | 1992-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL321966A1 (en) | Vaccine against viral hepatitis of b type | |
| CA2123612A1 (en) | Hybrid protein between cs from plasmodium and h bsag | |
| SE8102726L (sv) | Nukleotidsekvens som kodar ytantigenet av hepatit b-virus,vektor innehallande nemda nukleotidsekvens,forfarande for erhallande derav samt erhallet antigen | |
| AU8223187A (en) | T cell epitopes of the hepatitis b virus nucleocapsid protein | |
| AU9052091A (en) | Vaccines based on hepatitis b surface antigen | |
| HUT71791A (en) | Combined vaccines comprising hepatitis b surface antigen and other antigens | |
| CA2076744A1 (en) | Viral Agent Associated with Mystery Swine Disease | |
| CA2102918A1 (en) | Genetic vaccine for immunodeficiency viruses | |
| WO1995012677A3 (en) | Immunodominant human t-cell epitopes of hepatitis c virus | |
| OA09888A (en) | HLA-restricted hepatitis B virus CTL epitopes. | |
| NZ220612A (en) | 11 residue influenza virus peptide and vaccines | |
| ZA935723B (en) | Hepatitis A virus vaccine. | |
| EP0631506A4 (en) | VACCINES COMPRISING SELECTIVELY DEGLYCOSYLATED HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE PROTEINS. | |
| GB2264949B (en) | Measles virus recombinant poxvirus vaccine | |
| ZA915593B (en) | Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same | |
| PT85137A (en) | T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen | |
| EP0486106A3 (en) | Marek's disease virus vaccine | |
| OA09664A (en) | Virus/herbicide-resistance genes, processes for the preparation thereof and the use thereof | |
| AU2370592A (en) | Epitopes of the env protein of the hepatitis c virus | |
| ZA923070B (en) | Multiple hepatitis b virus surface proteins which form particles | |
| IL89118A0 (en) | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 | |
| EP0586065A3 (en) | Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same | |
| AU7909391A (en) | Epitopes of the pre-s region of hepatitis b virus surface antigen | |
| HU9203976D0 (en) | Vaccine based on modified herpes virus | |
| IL106592A0 (en) | Peptides,analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |